Table 1.
Lung cfu, × 105 | P ≤ | Brain cfu, × 105 | P ≤ | GXM*, mg/ml | P ≤ | |
---|---|---|---|---|---|---|
No IFN-γ therapy | ||||||
PBS | 12.2 ± 0.9 | 0.0220† | 26.0 ± 1.6 | 0.507† | 1.4 ± 0.1 | 0.109† |
IgG1 | 20.7 ± 2.6 | 0.0001‡ | 25.0 ± 2.7 | 0.001‡ | 1.5 ± 0.1 | 0.0001‡ |
IgG3 | 111.8 ± 14.1 | 0.0001§ | 34.2 ± 2.6 | 0.001§ | 2.5 ± 0.3 | 0.0001§ |
IFN-γ therapy | ||||||
PBS | 11.5 ± 1.8 | 0.012† | 12.8 ± 2.6 | 0.001† | 1.2 ± 0.2 | 0.0005† |
IgG1 | 8.0 ± 0.9 | 0.0002‡ | 5.4 ± 1.8 | 0.0001‡ | 0.5 ± 0.2 | 0.0001‡ |
IgG3 | 33.6 ± 4.3 | 0.0001§ | 29.4 ± 3.7 | 0.0001§ | 2.3 ± 0.3 | 0.0003§ |
Value is expressed as mean ± SD.
PBS vs. IgG1.
IgG1 vs. IgG3.
IgG3 vs. PBS (unpaired Student’s t test).